HTA324 Recent Landscape of Drug Re-Assessments by G-BA – What Is the Impact of New Evidence on the Benefit Assessment Outcome?
Abstract
Authors
K. Lach D. Meletiche
K. Lach D. Meletiche
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now